SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-011329
Filing Date
2024-03-15
Accepted
2024-03-15 09:02:00
Documents
15
Period of Report
2024-03-13
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jan-20240313.htm   iXBRL 8-K 26215
2 EX-99.1 a991_janoneregainscomplian.htm EX-99.1 8469
  Complete submission text file 0001628280-24-011329.txt   164579

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jan-20240313.xsd EX-101.SCH 1908
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jan-20240313_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jan-20240313_pre.xml EX-101.PRE 13055
16 EXTRACTED XBRL INSTANCE DOCUMENT jan-20240313_htm.xml XML 2812
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
JanOne Inc. (Filer) CIK: 0000862861 (see all company filings)

IRS No.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19621 | Film No.: 24752681
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)